Tag: Wingman CTO catheter
Reflow Medical receives approval in Japan for the Wingman catheter
Reflow Medical has announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved the Wingman chronic total occlusion (CTO) catheter. Reflow Medical has...
Wingman catheter granted expanded indication to cross CTOs in PAD
Reflow Medical has announced that they have received US Food and Drug Administration (FDA) clearance for an expanded indication for the Wingman crossing catheter...
Reflow Medical completes enrolment in the Wing-IT IDE CTO clinical trial
Reflow Medical has announced the completion of enrolment in its Wing-IT investigational device exemption (IDE) trial; a prospective, multicentre, nonrandomised study evaluating the ability...
Enrolment commences for Wing-IT IDE clinical trial of Wingman catheter
The first patients have been enrolled in a prospective, multicentre, non-randomised study intended to evaluate the ability of the Reflow Wingman Catheter (Reflow Medical)...
